SPY771.54+0.02%QQQ744.95+0.06%BTC/USD83,734.10−0.77%DIA517.45−0.01%GLD392.95−0.12%TLT79.30−0.03%
Benzinga

Amneal Pharmaceuticals Inc (AMRX) Stock Price, Quote, News & History

AMRXNASDAQ
Trade with Public
Trade with Public
$19.77
-0.035-0.18%
At close: Sep 25, 5:00 PM EST
$19.77
N/A
After Hours: 4:00 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Amneal Pharmaceuticals (AMRX) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$20.00
Close
$19.77
Volume / Avg.
2.44M / 2.14M
Day Range
$19.33 - $20.00
52 Wk Range
9.49 - 21.18
Market Cap
$6.89B
P/E Ratio
41.27
Dividend Yield
-
Exchange
NASDAQ
RSI
64
Short Interest
4.6%
Days to Cover
6.64

Recent Amneal Pharmaceuticals, Inc News

Salesforce To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday

Wall Street analysts made mixed price-target changes for LYFT, AMRX, JBHT, CRM, APPF, FLNC and CRWD.
Avi Kapoor

Two Years to Build or Pay 200% — Which US Pharma Stocks Win?

Trump sets a 2-year ultimatum for generic drugmakers to reshore U.S. production or face tariffs up to 200%.
Stjepan Kalinic

Eli Lilly, Regeneron Join FDA Pilot Designed To Accelerate US Manufacturing Readiness

FDA names seven companies to its PreCheck pilot to speed U.S. drug manufacturing reviews after receiving more than 80 applications.
Vandana Singh

Top 3 Health Care Stocks That May Collapse This Quarter

3 health care stocks flashing warning: CAH RSI 77.7, TGTX RSI 79.8, AMRX RSI 76.9; all overbought, but positive price action for TGTX.
Avi Kapoor

Why Is Amneal Pharmaceuticals Stock Gaining Today?

Amneal Pharmaceuticals rises premarket after $1.1B Kashiv BioSciences deal to expand biosimilars platform and tap $300B biologics opportunity, while raising FY26 outlook.
Nabaparna Bhattacharya

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
200.78M
Investing Cash Flow (TTM)
-212.37M
Financing Cash Flow (TTM)
69.63M
Free Cash Flow (TTM)
-12.31M
Capital Expenditure (TTM)
-213.09M
Net Change in Cash (TTM)
58.04M

Analyst Trends and Forecast

1
Apr
1
May
1
Jul
2
Aug
3
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$9.56B
PE Ratio (TTM)
41.27
PE Ratio (FWD)
16.92
PEG Ratio (TTM)
1.88
PS Ratio (TTM)
2.08
PB Ratio (TTM)
208.93
Earnings Yield % (TTM)
2.42%
Earnings Yield % (FWD)
5.91%
EV / EBITDA (TTM)
15.35
Price / EBITDA (TTM)
10.41
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.09

Company Debt

Total Debt
$2.67B
LT Debt
$2.56B
LT Debt Issuance (TTM)
$2.83B
LT Debt Repayment (TTM)
$104.05M
Total Cash
$127.64M
Debt to Equity
84.54
Issuance of Debt (TTM)
$2.93B
Repayment of Debt (TTM)
-$2.71B

Key Statistics

Open
$20.00
Close
$19.77
Volume / Avg.
2.44M / 2.14M
Day Range
$19.33 - $20.00
52 Wk Range
9.49 - 21.18
Market Cap
$6.89B
P/E Ratio
41.27
Dividend Yield
-
Exchange
NASDAQ
RSI
64
Short Interest
4.6%
Days to Cover
6.64

About

Sector
Health Care
Industry
Pharmaceuticals
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Amneal Pharmaceuticals (AMRX) stock?

A

You can purchase shares of Amneal Pharmaceuticals (NASDAQ:AMRX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Amneal Pharmaceuticals (AMRX) competitors?

Q

What is the forecast, or price target, for Amneal Pharmaceuticals (AMRX) stock?

A

Amneal Pharmaceuticals has a consensus price target of $17.30.

Q

What is the current price for Amneal Pharmaceuticals (AMRX)?

A

The stock price for Amneal Pharmaceuticals (NASDAQ: AMRX) is $19.77 last updated September 25, 2026 at 4:00 PM EDT.

Q

Does Amneal Pharmaceuticals (AMRX) pay a dividend?

A

There are no upcoming dividends for Amneal Pharmaceuticals.

Q

When is Amneal Pharmaceuticals (NASDAQ:AMRX) reporting earnings?

A

Amneal Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Amneal Pharmaceuticals (AMRX) going to split?

A

There is no upcoming split for Amneal Pharmaceuticals.

Q

What sector and industry does Amneal Pharmaceuticals (AMRX) operate in?

A

Amneal Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved